Importantly, anti-GCSF treatment led to reduced neoplasm numbers and a trend toward reduced tumor surface area compared with the isotype control group (Fig. 6K and L) which correlated with normalization of Neut/MDSCs and other circulatory and colonic immune cell populations in tumor-bearing mice. The gene discussed is CSF3; the disease is neoplasm.